Design, Synthesis and Cytotoxicity of Novel Chalcone Analogs Derived from 1-Cyclohexylpyrrolidin-2-one and 2,3-Dihydrobenzo[f]chromen-1-one

被引:8
作者
Brien, Kimberly A. [1 ,2 ]
Bandi, Ravi Kumar [3 ]
Behera, Ajaya Kumar [3 ]
Mishra, Bijay Kumar [3 ]
Majumdar, Poulomi [3 ]
Satam, Vijay [1 ,2 ]
Savagian, Mia [1 ,2 ]
Tzou, Samuel [1 ,2 ]
Lee, Megan [1 ,2 ]
Zeller, Matthias [4 ]
Robles, Andrew J. [5 ]
Mooberry, Susan [5 ,6 ]
Pati, Hari [3 ]
Lee, Moses [1 ,2 ]
机构
[1] Hope Coll, Div Nat Sci, Holland, MI 49423 USA
[2] Hope Coll, Dept Chem, Holland, MI 49423 USA
[3] Sambalpur Univ, Dept Chem, Sambalpur, Orissa, India
[4] Youngstown State Univ, Dept Chem, Youngstown, OH 44555 USA
[5] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA
[6] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA
关键词
Benzochromanone; Chalcones; Cytotoxicity; Tubulin; X-ray; SUBSTITUTED CHALCONES; ANTINEOPLASTIC AGENTS; DERIVATIVES; 2-ARYLIDENEBENZOCYCLOALKANONES; COMBRETASTATIN-A4; INHIBITORS; GROWTH; POTENT; CELLS; A-4;
D O I
10.1002/ardp.201100265
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two divergent series of novel chalcone analogs, one derived from 1-cyclohexylpyrrolidin-2-one and the other derived from 1-benzo[f]chromanone, were designed, synthesized and evaluated for cytotoxicity against two murine cancer cell lines. Two 1-benzo[f]chromanone analogs, 4g and 4j yielded moderate toxicity against both melanoma B16 and lymphoma L1210 cell lines with IC50 values between the range of 5 and 6?mu M. With an IC50 value of 3.4?mu M, compound 4g was also active against human MDA-MB-435 melanoma cells. X-ray structures of the beta-hydroxy ketone product (4a) and the a,beta-unsaturated ketone (4h) were collected, and confirm the syn-configuration between the carbonyl moiety and the beta-vinylic proton in 4h. X-ray structures of two 1-cyclohexylpyrrolidin-2-one derivatives were also obtained, and both showed an E-configuration for the double bond.
引用
收藏
页码:341 / 348
页数:8
相关论文
共 29 条
[21]   Antibacterial chalcones-bioisosteric replacement of the 4′-hydroxy group [J].
Nielsen, SF ;
Boesen, T ;
Larsen, M ;
Schonning, K ;
Kromann, H .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (11) :3047-3054
[22]   Licochalcone A: An inducer of cell differentiation and cytotoxic agent from Pogostemon cablin [J].
Park, EJ ;
Park, HR ;
Lee, JS ;
Kim, JW .
PLANTA MEDICA, 1998, 64 (05) :464-466
[23]   Design, synthesis and antiproliferative activity of some 3-benzylidene-2,3-dihydro-1-benzopyran-4-ones which display selective toxicity for malignant cells [J].
Perjesi, Pal ;
Das, Umashankar ;
De Clercq, Erik ;
Balzarini, Jan ;
Kawase, Masame ;
Sakagami, Hiroshi ;
Stables, James P. ;
Lorand, Tamas ;
Rozmer, Zsuzsanna ;
Dimmock, Jonathan R. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (04) :839-845
[24]   ANTINEOPLASTIC AGENTS .291. ISOLATION AND SYNTHESIS OF COMBRETASTATINS A-4, A-5, AND A-6 [J].
PETTIT, GR ;
SINGH, SB ;
BOYD, MR ;
HAMEL, E ;
PETTIT, RK ;
SCHMIDT, JM ;
HOGAN, F .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (10) :1666-1672
[25]   ANTINEOPLASTIC AGENTS .124. ISOLATION, STRUCTURE, AND SYNTHESIS OF COMBRETASTATIN-A-1 AND COMBRETASATIN-B-1, POTENT NEW INHIBITORS OF MICROTUBULE ASSEMBLY, DERIVED FROM COMBRETUM-CAFFRUM [J].
PETTIT, GR ;
SINGH, SB ;
NIVEN, ML ;
HAMEL, E ;
SCHMIDT, JM .
JOURNAL OF NATURAL PRODUCTS, 1987, 50 (01) :119-131
[26]  
Satam V. S., 2011, LETT DRUG D IN PRESS
[27]   Cytotoxic and inhibitory effects of 4,4-dihydroxy chalcone (RVC-588) on proliferation of human leukemic HL-60 cells [J].
Saydam, G ;
Aydin, HH ;
Sahin, F ;
Kucukoglu, O ;
Erciyas, E ;
Terzioglu, E ;
Buyukkececi, F ;
Omay, SB .
LEUKEMIA RESEARCH, 2003, 27 (01) :57-64
[28]   Developments of Combretastatin A-4 Derivatives as Anticancer Agents [J].
Shan, Y. ;
Zhang, J. ;
Liu, Z. ;
Wang, M. ;
Dong, Y. .
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (04) :523-538
[29]  
Sharath N., 2011, J PHARM RES, V1, P46